Grifols (GIFLF) Net Cash Flow (QoQ) (2010 - 2020)

Grifols (GIFLF) Net Cash Flow (QoQ) (2010 - 2020) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn
10 Grifols - - -

Historic Data

Download Data
DateValue
Mar 31, 2020 59.92%
Mar 31, 2019 -141.23%
Jun 30, 2018 -312.72%
Mar 31, 2018 -94.87%
Jun 30, 2017 -93.50%
Mar 31, 2017 5,379.98%
Dec 31, 2016 88.08%
Dec 31, 2015 -577.30%
Sep 30, 2015 -81.08%
Jun 30, 2015 410.58%
Mar 31, 2013 107.76%
Dec 31, 2012 -395.97%
Sep 30, 2012 -63.10%
Jun 30, 2012 137,778.57%
Mar 31, 2012 -99.64%
Dec 31, 2011 -97.03%
Sep 30, 2011 589.54%
Jun 30, 2011 1,035.35%
Mar 31, 2011 -125.97%
Dec 31, 2010 67.74%